In addition to its role in tRNA aminoacylation, Escherichia coli threonyl-tRNA synthetase is a regulatory protein which binds a site, called the operator, located in the leader of its own mRNA and inhibits translational initiation by competing with ribosome binding. This work shows that the two essential steps of regulation, operator recognition and inhibition of ribosome binding, are performed by different domains of the protein. The catalytic and the C-terminal domain of the protein are involved in binding the two anticodon arm-like structures in the operator whereas the N-terminal domain of the enzyme is responsible for the competition with the ribosome. This is the first demonstration of a modular structure for a translational repressor and is reminiscent of that of transcriptional regulators. The mimicry between the operator and tRNA, suspected on the basis of previous experiments, is further supported by the fact that identical regions of the synthetase recognize both the operator and the tRNA anticodon arm. Based on these results, and recent structural data, we have constructed a computer-derived molecular model for the operator-threonyl-tRNA synthetase complex, which sheds light on several essential aspects of the regulatory mechanism.
Introduction
Aminoacyl-tRNA synthetases (aaRSs) are among the ancestral RNA binding proteins, and are thus central to the question of the origin of life (Nagel and Doolittle, 1995) . Extensive crystallographic structure analysis of aaRSs has revealed that the enzymes are assembled in a modular fashion with a core domain responsible of the aminoacyl-adenylate synthesis and aminoacylation of an RNA of about the size of the acceptor arm of a modern tRNA (Delarue and Moras, 1993; Schimmel et al ., 1993) . This ancient tRNA synthetase acquired additional domains to establish specific contacts with other parts of the tRNA (Delarue and Moras, 1993; Cusack, 1997) . Recent investigations have revealed that aaRSs may have multiple functions related to other critical cellular activities such as cellular fidelity, RNA splicing, RNA trafficking, mRNA quality control, apoptosis, and translational control (for a review, see Martinis et al ., 1999) . Some of these functions have been described as examples of molecular exaptation, i.e. the appropriation of a macromolecule with a defined function for a completely different purpose during evolution (Weiner and Maizels, 1999) . Several noncanonical aaRS functions were proposed to rely on specific interactions with RNAs that share some resemblance to tRNA (Florentz and Giegé, 1995) .
Escherichia coli threonyl-tRNA synthetase (ThrRS) provides a characteristic example of the strategies used by an aaRS to achieve different functions: aminoacylation of tRNA Thr , proofreading of misaminoacylated tRNA Thr (Sankaranarayanan et al ., 1999; Dock-Bregeon et al ., 2000) , and autoregulation. E. coli ThrRS negatively regulates the expression of its own gene ( thrS ) at the translational level (Springer et al ., 1985) . The protein binds to a site in the leader of its own mRNA, upstream of the Shine-Dalgarno sequence, and inhibits translational initiation by competing with binding of the 30S ribosomal subunit (Moine et al ., 1990) . The cis -acting region of the thrS leader mRNA, essential for control, is called the operator and is composed of four structural domains (Fig. 1A) . Domain 1 and the 3 ¢ -part of the single-stranded linker domain 3 constitute the ribosome binding site (Sacerdot et al ., 1998) . Domains 2 and 4 form two hairpins, which are recognized by ThrRS in the same way as the genuine anticodon loop of tRNA Thr . The first base of the anticodon of tRNA Thr isoacceptors, can be C, G or U, whereas the second (G) and the third (U) are essential for aminoacylation (Hasegawa et al ., 1992) . Similarly, any change in the first base of the anticodon-like sequences in domain 2 (CGU) and 4 (UGU) has a limited effect on control, whereas a change in the second or third base has a dramatic effect (Romby et al ., 1996) . Furthermore, the replacement of the anticodon-like CGU sequence in the operator by CAU, the tRNA Met anticodon, is sufficient to abolish control by ThrRS and to establish control by methionyl-tRNA synthetase both in vitro and in vivo . Finally, the stoichiometry of the different RNA-ThrRS complexes revealed that two tRNA Thr molecules bind to the enzyme whereas only one thrS operator interacts with the homodimeric enzyme (Romby et al ., 1996) . These data led us to propose a model in which the two anticodon-like domains of the operator bind symmetrically to the two tRNA Thr anticodon recognition sites (one per subunit) of the dimeric enzyme.
The recent determination of the crystal structures of ThrRS complexed with two tRNA Thr 2 molecules (Sankaranarayanan et al ., 1999) , and that of the isolated domain 2 bound to ThrRS deprived of its N-terminal domains (Torres-Larios et al ., 2002) allowed us to investigate the similarity between tRNA and operator recognition. Our strategy consisted of changing the amino acids involved in RNA recognition, and investigating the effect of these changes on both aminoacylation and control. All experiments were performed both in vitro and in vivo . These results permitted the construction of a molecular model of the whole operator-ThrRS complex, which suggests how the operator might wrap around ThrRS and how the enzyme is involved in preventing the ribosome from binding the mRNA.
Results

The experimental strategy
The crystallographic structure of dimeric ThrRS complexed with two tRNA 2 Thr molecules (Sankaranarayanan et al ., 1999) showed that the acceptor stem and the anticodon loop carrying the previously characterized identity Thr (B). A. Summary of ThrRS footprinting data as shown on the secondary structure model of the thrS leader between positions -118 and + 3 ( + 1 is the A of the AUG initiation codon). RNase V1 cleavages are shown by triangles and RNase T1 cuts by arrows. Green and red symbols are for protected and non-protected cleavages respectively. The nucleotides, protected by ThrRS at one of their Watson-Crick positions, are encircled. Protected riboses are shown by green squares. The red asterisk at G-30 stands for increased reactivity induced by ThrRS binding. SD, Shine-Dalgarno sequence. The conserved nucleotides found in 14 different putative thrS leader regions in Gram-negative bacteria are shown as follows: red for strictly conserved and light blue for conserved purine/pyrimidine. The amino acids in interaction with domain 2 as deduced from the crystal structure (Torres-Larios et al ., 2002) are shown. In domain 4, the postulated contacts derived from the mutational study are also given. The superrepressor enzyme (E258K/E259K) has an increased affinity for the isolated domains 2 and 4, and additional contacts with the upper stems are suspected to occur. B. The nucleotides of tRNA Thr 2 interacting with ThrRS are shown. The cross-subunit interactions are marked with a star. The amino acids that were mutated are in red when the change has no effect on aminoacylation, in blue for weak effect on aminoacylation, and in green for strong effect on aminoacylation. Those in interaction with the tRNA, which were not mutated, are in black. The effect on control and/or operator-ThrRS affinity is indicated as stars with the same colour code as for aminoacylation. The identity nucleotides are shown in red.
nucleotides (Hasegawa et al ., 1992) interact directly with the enzyme (schematized in Fig. 1B) . As is the case for other class II aaRSs, the catalytic domain of ThrRS approaches the major groove side of the acceptor stem in order to interact with the CCA end. In addition, the Nterminal domain makes substantial contacts with the minor groove of the acceptor stem, a feature specific to ThrRS. These contacts involve a region of the N-terminal domain (amino acids 200-219) and the first two basepairs of the acceptor stem in the minor groove. On the anticodon side, bases 35-38 are splayed out upon ThrRS binding and all of the bases in the loop interact with the C-terminal domain through at least one hydrogen bond (schematized in Fig. 1B ). In addition, cross-subunit interactions occur between three regions (amino acids 347-349, 500-503, 324-325) of one subunit of the enzyme and phosphates of the anticodon and the acceptor stems of the tRNA mainly bound to the other subunit ( Fig. 2A) .
We changed most of the residues of ThrRS in contact with tRNA Thr ( Fig. 2A ), often to alanine. Additional mutations were also suggested by the recently determined crystal structure of the D NThrRS-domain 2 complex (Torres-Larios et al ., 2002) . Mutations were made on a tester plasmid (pTet thrS D H) carrying the thrS gene, without its translational operator, under control of an IPTGinducible derivative of the lac promoter. The effect of these changes was analysed by testing the ability of these mutants to complement a chromosomal disruption of the thrS gene. The complementation test was performed under two sets of conditions: (i) in the absence of IPTG, where the tester plasmid synthesises ThrRS to a level identical to that of a normal chromosomal copy of the gene; (ii) in the presence of IPTG, where the plasmid synthesises 25-fold more ThrRS than the chromosomal copy of thrS (see Experimental procedures ). The effect of amino acid changes on regulation was analysed using a strain that carries a wild-type chromosomal copy of thrS at its normal locus and a thrS-lacZ fusion cloned in bacteriophage l and integrated at att l on the E. coli chromosome. The strain was transformed with the wild-type or mutant tester plasmids, and b -galactosidase levels were measured in the presence of IPTG. Quantitative immunoblots show that the steady-state level of ThrRS made from the tester plasmid is identical whether it carries a wild-type or any of the mutant versions of the thrS gene (data not shown). Therefore, any defect in control or complementation can be interpreted in terms of activity rather than stability.
Most of the mutant proteins were overexpressed, purified, and tested for their catalytic properties. The affinity of the different mutated enzymes for domains 2 and 4 or the complete thrS operator was measured using the ability of the mRNA fragments to compete with tRNA Thr for aminoacylation (Ki). The interactions between the mutant enzymes and the operator was also tested by footprinting experiments using RNase T1 (specific for unpaired G) and Fe-EDTA (ribose attack).
Mutations in the C-terminal domain of ThrRS strongly affect complementation and tRNA aminoacylation kinetic constants
Although only the second and third bases of the anticodon are identity determinants, the crystal structure of the tRNA Thr -ThrRS complex shows that all the three bases of the anticodon interact with the protein. Residue C34 interacts with the side chain of N575, G35 with the highly conserved acidic residue E600, and U36 with the strictly conserved R609 (Table 1 ; Figs 1B and 2A). These three amino acids were independently changed to alanine. The N575A mutant enzyme fully complemented the thrS chromosomal disruption whereas the E600A and R609A mutants, in particular E600A, could not under noninduced conditions (see Table 1 ). In vitro , the N575A enzyme showed a defect in K M , but had a normal kcat, whereas E600A and R609A mutants both had K M and kcat defects, although the decrease in kcat was limited for R609A (Table 1) . Thus the in vivo and in vitro data show that changes in the amino acids that recognize the second and third bases of the anticodon have more dramatic effects than alteration of N575, which interacts with the first base.
The interaction of the C-terminal domain of ThrRS with the anticodon loop of tRNA Thr is not restricted to the anticodon itself (Fig. 1B) . Indeed, bases U32 and U33 interact with side chains of N575 and D549, respectively, whereas the modified base, mt 6 A37, interacts with the side chain of R583. In addition, the side chain of K577 partially occupies the space created in the middle of the loop by the splaying out of the bases. Changing N575 or D549 to A allowed full complementation of the thrS disruption whereas the K577 to A and R583 to H changes had clear effects on complementation (Table 1) . Previous experiments showed that the R583H mutant had a K M rather than a kcat defect (Springer et al ., 1989 ) and the present data shows that K577A mutant has a strong K M and a limited kcat effect (Table 1) .
In summary, these results show that changes in the amino acids that interact with the anticodon loop generally affect both their ability to complement thrS null strains in vivo (except for N575A and D549A) and their ability to aminoacylate tRNA Thr in vitro (in all cases tested). For the majority of the mutants tested in vitro , the effect on tRNA aminoacylation was at the level of K M . However, as the E600A mutant shows significant effect on kcat, these data also suggest that binding of the anticodon contributes to the correct positioning of the acceptor stem in the catalytic cleft.
The C-terminal domain of ThrRS is essential for control
We next investigated the effect of the C-terminal domain mutants on control in vivo and on the binding affinity for mRNA in vitro . We first compared the effect of the tester plasmid, carrying wild-type or mutant thrS alleles, on b-galactosidase expression from thrS-lacZ translational fusions. We used both a wild-type and an operator constitutive thrS-lacZ fusion. The wild-type fusion produced 2393 units of b-galactosidase in the presence of pTet99, the control plasmid (Table 2 ). In the presence of the tester plasmid (pTetthrSDH) carrying the wild-type thrS gene and overproducing ThrRS (induced conditions), only 20 units of b-galactosidase were produced and the repression factor was thus 117-fold. In strains carrying the operator constitutive thrS-lacZ fusion, the b-galactosidase level was identical in the presence of either the wild-type tester plasmid or any of its mutant derivatives (data not shown).
Mutations in the amino acids involved in interactions with the anticodon showed that N575A had a clear, but limited effect on control (repression factor of 41 instead of 117), whereas E600A and R609A abolished control (repression factors of 0.8 and 0.9 respectively: see Table 2 ). The effects of these mutations on control can be directly correlated to their effects on mRNA recognition in vitro: The N575A mutation slightly increased the Ki value for the whole operator whereas the E600A and R609A mutations decreased the binding affinity by one to three orders of magnitude (Table 2) . The E600A change also decreased the affinity for the isolated domains 2 and 4, whereas the N575A mutation had no effect (Table 2) . Finally, the R583H and K577A mutations had a strong effect on regulation, correlated with a strong decrease in the affinity of K577A enzyme for the operator whereas D549A behaved as the wild-type enzyme ( Table 2) .
In summary, the recognition of the conserved G/U nucleotides of the anticodon-like triplet is essential for regulation and all the mutations in the C-terminal domain had analogous effects on aminoacylation and control. In addition, the C-terminal mutations tested had an equivalent effect on the affinity of the isolated domains 2 and 4, Table 1 . Complementation and aminoacylation with the mutated derivatives of ThrRS.
Interaction modified aa change Name of plasmid
Colony size Aminoacylation indicating that the apical loops of both domains interact with ThrRS in a similar way (Table 2) .
Cross-subunit contacts of ThrRS with the anticodon arm contribute to aminoacylation and control
Each of the tRNAs bound to the ThrRS dimer also makes contacts with the other subunit. These cross-subunit contacts involve the ribose-phosphate backbone of the anticodon and acceptor stems of the tRNA ( Fig. 1B ; Table 1 ).
In the anticodon stem, the phosphate of C28 interacts with the side chains of S347 and R349 and its ribose with the side chain of N502. The phosphate of G29 also interacts with the side chains of R349 and Y348. Footprinting on tRNA bound to ThrRS had shown previously that phosphates 27-29 were indeed protected by ThrRS (Théobald et al., 1988) . Finally, the phosphate group of U66 interacts with the side chain of N324. Several amino acids involved in these cross-subunit contacts were changed to A, except for Y348 which was changed to F. Only mutations located in the loop containing residues S347-R349 (Table 1) affected complementation. In vitro, the catalytic parameters of the mutant enzymes were not significantly altered except for R349A mutant enzyme, which showed a 20-fold increase in the K M compared with the wild-type enzyme (Table 1) . Interestingly, all of the mutations in the amino acids which interact with either C28 or G29 of the anticodon stem of the tRNA (S347A, Y348F, R349F, N502A) strongly decreased repression. This is correlated with a decreased affinity of the purified Y348F, R349A and N502A mutant enzymes for the operator (Table 2) . On the contrary, the N324A mutation, which affects the interaction of ThrRS with U66 in the acceptor stem, had no effect on repression, and showed a wild-type affinity for the operator (Table 2 ). In conclusion, the data showed that the crosssubunit contacts involving the anticodon stem contribute more to the efficiency of control than to aminoacylation.
The amino acids that recognise the acceptor stem are not involved in control
Former work had shown that the first two basepairs (G1-C72 and C2-G71) of the acceptor arm are important iden- 28.1 ± 1.6 85 0.025 ± 0.005 2.5
IBPC5421lMD20-10 and IBPC5421lMD20-10BS4-9, carrying, respectively, a wild-type and an operator constitutive mutation on the fusion, were transformed with pTetthrSAEH and its mutated derivatives, the transformants were purified and b-galactosidase measurements performed as under Materials and Methods.
(1) The overproduction of the superrepressor enzyme inhibits cell growth, therefore the preculture was carried out in the presence of 50 mM IPTG, and the culture with 200 mM IPTG instead of 1 mM for both preculture and culture for the other transformants.
Other experimental details are given in Experimental procedures. ND, not determined.
tity determinants (Hasegawa et al., 1992) . The N-terminal domain essentially interacts with the first two basepairs of the acceptor arm via the minor groove: the side chain of Y205 interacts with G1 and that of Y219 with the 2¢OH of G71. Changing these two residues to F did not affect the capacity of the mutant enzymes to complement the chromosomal deletion of thrS (Table 1 ). In addition, S367, which is located in the catalytic domain and interacts with the 5¢-phosphate of G1, was changed to A. This mutation caused a weak complementation defect (Table 1) . The Y205, Y219F and S367A enzymes showed a 10-fold increase in the K M for tRNA Thr compared with wild-type ThrRS. Despite their aminoacylation defects, the Y205, Y219F and S367A enzymes were able to efficiently repress a thrS-lacZ fusion in trans (Table 2 ). This is explained by the fact that the binding affinity of the mutant enzymes for the whole operator is not affected ( Table 2) . Also, footprinting assays revealed that the Y219F and S367A mutant enzymes protected both loops of domains 2 and 4 against RNase T1 similarly to wild-type enzyme (data not shown). Thus, as previously suspected, the data showed that the amino acids involved in the acceptor arm binding do not recognize the operator.
The N-terminal domain is responsible for the competition with the ribosome during regulation
As the possibility remained that several simultaneous amino acid changes of the acceptor arm binding site are required to alter operator recognition, we tested the effect of a deletion of the whole N-terminal domain of ThrRS on both the enzyme activity and regulation. In this mutant enzyme (DNThrRS), all the contacts with the minor groove side of the acceptor stem are lacking. As expected, the plasmid carrying the 5¢-terminally truncated gene was unable to complement the chromosomal deletion of thrS normally and the protein was defective in tRNA Thr aminoacylation (Table 1) . However, the binding affinity of the mutated enzyme for the operator was almost identical to that of the wild-type enzyme (Table 2) . Surprisingly, the truncated protein completely lost the ability to repress a thrS-lacZ fusion in trans in vivo (Table 2) . This unexpected behaviour is most likely due to its inability to compete with the ribosome. This hypothesis was tested in toeprinting experiments, which allow measurement of ribosome binding at the thrS translation initiation site, detected by a reverse transcriptase stop at position +16 of thrS mRNA (+1 being the adenine of the AUG initiator codon) (Moine et al., 1990) . The addition of increasing concentrations of wild-type ThrRS decreased the toeprint at position +16, indicating a competition between ribosome and ThrRS binding to the thrS message (Fig. 3, left) . In the presence of the truncated protein, the toeprint is insensitive to the enzyme concentration (Fig. 3, right) , indicating that, despite ThrRS binding, the ribosome is able to initiate protein synthesis. In conclusion, these data strongly suggest that the N-terminal domain is involved in blocking the access of the ribosome.
Evidence for specific mRNA-ThrRS contacts
The comparison of the crystal structures of the DNThrRSdomain 2 and ThrRS-tRNA Thr complexes predicts that interactions that have no equivalent in the tRNA Thr occur between the ribose-phosphate chain of U-18 and G-19 of the operator and K246 and K249 (Torres-Larios et al., 2002) . These lysine residues, which make no contacts with the tRNA, were individually mutated to alanine. These mutations did not affect the capacity of the mutant enzymes to complement the chromosomal deletion of thrS. In addition, the mutant enzymes had catalytic parameters identical to the wild-type enzyme (Table 1) . However, mutation K246A significantly decreased the efficiency of control in vivo, whereas the K249A mutation had a weaker effect (Table 2) . This again is well correlated with the fact that K246A and K249A mutant enzymes had a 10-fold and 2.5-fold decreased binding affinity for the operator respectively (Table 2) . Thus these data show that the two lysines 246/249 increase the stability of the operator-ThrRS complex and the repression in vivo without affecting aminoacylation. Additional evidence indicated that the upper helical parts of domains 2 and 4 of the operator are recognized by ThrRS differently to tRNA. In a previous work, we isolated mutations in the thrS structural gene able to compensate a cis-acting operator defect (Springer et al., 1989) . Two independent isolates were shown to carry the double mutation E258 and E259 to KK in the catalytic domain. Interestingly, this mutant represses expression of a wild-type thrS-lacZ fusion to an extreme level, i.e. 1559fold (see pTetthrSDH4-11-8, Table 2 ). Furthermore, the binding affinity of the purified super-repressor to either the whole operator or to its domain 2 or domain 4 fragments is increased by two orders of magnitude compared with wild type (Table 2) . However, the super-repressor enzyme shows the same aminoacylation activity as the wild-type enzyme ( Table 1 ). The super-repressor was shown to compensate for various operator mutations in a different way. An operator mutation in the upper part of the stem (C-16AEU) of domain 2 was fully compensated; a mutation in the lower part of the same stem (G-40AEA) is only partially compensated whereas mutations in the anticodon-like loop of domain 2 were not. This allelespecific compensation suggests that the double mutations E to K created supplementary interactions with the upper part of domain 2. As the affinity of the super-repressor was also increased for the isolated domain 4, we propose that identical contacts involving K258/K259 also occur with the upper stem of domain 4. These additional contacts only occur between the mutant enzyme and the operator but not the tRNA, as the aminoacylation parameters are not significantly changed.
A molecular model for the interaction between ThrRS and the whole operator
The present experimental data are well correlated with the crystal structures of tRNA-ThrRS, and of domain 2-DNThrRS complexes. In particular, the mutagenesis data (Table 2) indicate that ThrRS recognises domain 2 similarly either in its isolated form or inside the whole operator. We have also shown that the N-terminal domains of ThrRS are not required for the whole operator binding and that the structure of the core enzyme does not show any significant difference with the previously reported structures of free DNThrRS or of ThrRS in complex with either tRNA or domain 2. Therefore, the molecular model for the whole operator bound to ThrRS was built using the crystallographic co-ordinates of the whole enzyme from the tRNA-ThrRS complex (Sankaranarayanan et al., 1999) , and of domain 2 from the domain 2-DNThrRS complex (Torres-Larios et al., 2002) . The model further integrates stereochemical constraints, footprinting data (Moine et al., 1990) , Fig. 1A , and mutagenesis studies on ThrRS (this work) and the operator (Brunel et al., 1993) .
Domain 2 contains two essential regions for ThrRS binding and for regulation, the apical loop and the internal loop (Brunel et al., 1993) . The comparison of the crystal structure of the tRNA-ThrRS complex with the domain 2-DNThrRS complex revealed that the C-terminal domain recognizes the anticodon loop of the tRNA and the apical loop of domain 2 similarly (Torres-Larios et al., 2002) . The internal loop of domain 2 adopts a particular fold constrained by two base triples, C-19/G-42-C-22 and C-21/A-44-U-18. In addition, A-20 is stacked within the groove, and interacts with U-41 (O2), whereas U-43 bulges out of the loop. This unusual fold contributes to induce a better fit between ThrRS and the helical part of domain 2 of the operator than with the anticodon stem of the tRNA (Torres-Larios et al., 2002) .Although domain 4 has a weaker affinity than domain 2 for ThrRS, our data suggests that the C-terminal domain of ThrRS recognizes the anticodon-like sequences of domains 2 and 4 similarly ( Table 2) . Therefore, the helical domain 4 was built to occupy the same binding site as domain 2. The apical loop of domain 4 contains one additional residue compared with that of domain 2. An increased RNase V1 cleavage was detected at A-99 upon ThrRS binding (Moine et al., 1990) , suggesting that this adenine residue stacks on the closing basepair C-100/G-91. Thus, the -98UUUGUUG-92 sequence was modelled, based on the crystal structure of domain 2 loop so that U-94 and G-95 (corresponding to U-31 and G-32 in domain 2) interact with R609 and E600 respectively. However, sequence differences at the wobble base (U-96 at equivalent position of C-33 in domain 2) and at the nucleotide 3¢ of the anticodon triplet (U-93 in domain 4 instead of G-30 in domain 2) disrupt contacts with the enzyme (Fig. 1) . This should account for the lower affinity of domain 4 and for the fact that replacing the loop of domain 2 with that of domain 4 decreased both mRNA binding affinity and control in vivo (Romby et al., 1996) . Otherwise, domain 4 lacks a motif similar to the internal loop of domain 2, but contains two unpaired nucleotides. Changing the bulged A-107 to U, was shown to allow the formation of a more regular helix, and to decrease both control and ThrRS binding (Brunel et al., 1993) . The two unpaired nucleotides were built bulging out to bend the upper part of the domain 4 helix towards the enzyme. This accounts for the increased affinity of the super-repressor enzyme for domain 4 relative to wild-type ThrRS. However, in the absence of additional structural constraints, the orientation of the bulged residues and thus of the whole helical domain may differ from that proposed.
As nucleotides of domain 3 are accessible to singlestranded specific probes in the presence of the enzyme, no tight interaction is expected to occur with the enzyme (Moine et al., 1990) . Thus the conformation of domain 3 should be rather loose and dynamic in solution, and domain 3 was modelled as a single-stranded linker ( Fig. 2B and C) . The model predicts that the minimal length of domain 3 compatible with an optimal binding of ThrRS to domains 2 and 4 is 12 nucleotides. In agreement with this hypothesis, a set of deletions in domain 3 indicates that a length of 19 nucleotides permits control, whereas a length of 6 does not .
Discussion
How extensive is the mimicry between thrS operator and tRNA Thr ?
Although mimicry between the thrS operator and tRNA Thr isoacceptors has been suspected for quite a while, the present work combined with the recent determination of the crystal structure of domain 2 bound to DNThrRS, allows a precise definition of its extent. The most striking similarities are found in the way the C-terminal domain of the protein binds to domain 2 and 4 of the operator and the anticodon arm of tRNA. Our analysis shows that most of the residues, which recognize the tRNA anticodon loop are essential for both aminoacylation and control. The comparison of the crystal structures of tRNA-ThrRS and domain 2-DNThrRS complexes reveals that the same amino acid residues interact with analogous nucleotides in both anticodon stem-loops, and that both loops bind the enzyme with the same induced-fit mechanism. In particular, the loop adopts the characteristic conformation with the splayed out bases, and the nucleotides G-32, and U-31 analogous to the G35 and U36 in tRNA, make a lateral basepair. As regards domain 4, for which no crystal structure is available, we suspect that the anticodon loop adopts a conformation close to that of domain 2. This is supported by the analogous effect of the different amino acid changes on ThrRS binding to the isolated domains 2 or 4 ( Table 2) .
Mimicry can also be extended to the recognition of the anticodon stem, as mutations of the amino acids involved in cross-subunit contacts affect both aminoacylation and control. Indeed, the two protein loops (S347-R349, E500-N502) of one subunit that interact with the anticodon stem (C28 and G29) of the second tRNA also make contacts with the equivalent positions -38/-39 of the isolated domain 2 (Torres-Larios et al., 2002) . Also, footprinting experiments show that ThrRS induces protections from Fe-EDTA and RNase V1 at equivalent positions of the ribose-phosphate backbone in domain 2 (at -39/-41) and domain 4 (-103/-104) (Fig. 1A) . Together, these data show that the anticodon stem-loop structure of tRNA and the equivalent regions of domains 2 and 4 of the operator bind ThrRS in a very similar way (Fig. 2B) . They also suggest that the anchoring of both the tRNA and the operator is primarily governed by base-specific interactions between the anticodon-binding domains and the loops of both RNAs. This RNA mimicry links the two functions of the enzyme in a coherent manner as it permits an efficient competition between the two RNA molecules for ThrRS binding. This competition was shown to be also responsible for growth rate dependent regulation of the enzyme (Comer et al., 1996) .
However despite the high degree of mimicry, the present study and the comparison between the two crystal structures suggest that the path used by the helical domains of domain 2 and tRNA diverge slightly (Torres-Larios et al., 2002) . Several observations indicate that the helical domains of the operator make closer contacts with the catalytic domain of ThrRS than the anticodon arm of tRNA: (i) mutations that disrupt the cross-subunit interactions have a more pronounced effect on operator recognition and control than on aminoacylation; and (ii) mutations of either K246 or K249 decrease control but have no effect on aminoacylation. In addition, the superrepressor ThrRS mutant enhances control but not aminoacylation, most likely by allowing additional contacts with the upper stem of both domains 2 and 4. In domain 2, these closer contacts are promoted by the particular fold of the internal loop, and results in a stacking of A-20 upon L345, adjacent to residues S347-R349 and K246/249, which contact the ribose-phosphate backbone (Fig. 1) . In domain 4, a role equivalent to the internal loop could be played by the bulged residues. However, domains 2 and 4 are not equivalent: the former is the main ThrRS binding domain (Brunel et al., 1993) and is located adjacent to the ribosome binding site whereas the latter, located further upstream, is known to play an auxiliary role by increasing ThrRS affinity.
The regulatory mechanism involves the N-terminal domain of ThrRS
The process of protein-mediated translational repression can be divided into two main events. The first event is the binding of the repressor to its operator and the second is the consequence of that binding on translation initiation. Our data provide some clues as to how both events occur. The initial recognition step is most probably the binding of ThrRS to domain 2 of the operator, because of its intrinsically higher affinity for the enzyme. We believe that the correct positioning of domain 2 orients domain 3 to promote the attachment of domain 4 to the other subunit of the enzyme. The simultaneous binding of domains 2 and 4 to ThrRS is only possible because they are separated by domain 3, a linker of sufficient length and flexibility. The anchoring of the RNA results from base-specific contacts with the anticodon-like loops and the orientation of both domains 2 and 4 is further stabilized by contacts involving the ribose-phosphate backbone. The model presented in Fig. 2B provides a possible path for the mRNA, which strongly supports the hypothesis that the two anticodon-like domains of the operator bind symmetrically to the two tRNA Thr anticodon recognition sites (one per subunit) of the dimeric enzyme. The formation of the ThrRS-operator complex also involves local and essential conformational changes of the operator. The most spectacular one being the spreading out of the bases of the anticodon-like bases.
As regards the second event, the effect of ThrRS binding on translation, previous experiments have shown that the repression mechanism is mainly based upon a competition between the ribosome and the synthetase (Moine et al., 1990) , i.e. on the mutually exclusive binding of one or the other molecule. We suspect that the competition occurs at an early step of initiation before the formation of the ternary complex between 30S, initiator tRNA and thrS mRNA. The simplest way to achieve exclusive binding of ribosome or synthetase would be if both molecules were to share a common recognition site on the mRNA as is the case in the repression of the R17 replicase cistron by coat protein (Witherell et al., 1991) . However, this is not the case here as ThrRS binds to domain 2 and 4 and the ribosome to domains 1 and the 3¢-end of domain 3 (Sacerdot et al., 1998) . Although the binding sites of both molecules are physically separated, they are adjacent to each other (Fig. 2C) . This proximity is essential for regulation as a duplication of nine nucleotides, which increases the distance between domain 2 and the Shine-Dalgarno sequence, abolishes repression by ThrRS (Springer et al., 1986) . The importance of the proximity is also indicated by phylogeny. Sequence alignment of thrS genes from different Gram-negative bacteria reveals that domain 2, which is conserved, is always located immediately upstream (from 0 to 2 nt) of the Shine-Dalgarno sequence.
Once bound to domain 2, the anchoring site, the catalytic domain of ThrRS makes contacts with nucleotides in the upper part of its stem. For instance, K246 and K249 interact with the ribose-phosphate chain of U-18 and G-19 of domain 2, the former interaction being important for regulation (Table 2 ). These contacts are essential for fixing the position of domain 1 as it emerges from the core of ThrRS (Fig. 2C) . The model indicates that the Nterminal domain of ThrRS is extremely close to the 3¢-part of domain 3 and to the Shine-Dalgarno sequence of the operator. Our data clearly designate the N-terminal domain of ThrRS as responsible for the inhibition of ribosome attachment. This inhibition can be explained in two different ways. First, the N-terminal domain could sequester and/or change the conformation of domain 1 or 3 to which the ribosome must bind to initiate translation. Second, the N-terminal domain of the synthetase could (sterically?) impede ribosome binding. As footprinting and genetic experiments indicated that ThrRS neither interacts with domains 1 and 3 nor induces any conformational change, the steric hindrance model is favoured.
Relevance to other regulators and evolutionary considerations
This study shows that the two main phases of the regulation, operator recognition and inhibition of ribosome binding, are performed by different domains of the protein.
ThrRS is a thus modular protein, a property shared by many transcriptional regulators, but not yet demonstrated in the case of translational regulators. Interestingly, ThrRS, in addition to its modular structure, shares quite a few properties with some classical transcriptional regulators. The enzyme is homodimeric and binds symmetrically to the two anticodon-like stem-loop structures (one per subunit) that can be compared with sequences with a dyad symmetry. Furthermore, ThrRS most probably binds domain 2 and 4 co-operatively (Romby et al., 1996) .
As mentioned before, the modular structure of the aaRSs has been proposed to be the consequence of successive acquisition of different functions associated with modern enzymes (Schimmel et al., 1993) . The catalytic domain, responsible for adenylate synthesis and aminoacylation of an RNA of about the size of the acceptor arm of a modern tRNA, is considered to be the ancient form of the synthetase. With the appearance of more evolved RNA structures carrying an anticodon stem, the synthetases acquired another module involved in the recognition of this supplementary RNA structure. The Nterminal domain, was added to improve tRNA Thr recognition (via interactions with its acceptor arm) and fidelity Sankaranarayanan et al., 2000) . The need for feedback regulation was probably satisfied much more recently by re-routing two of the domains of the synthetase towards mRNA recognition and inhibition of ribosome binding. This re-routing had to be performed without any loss of essential synthetase functions, in particular tRNA Thr recognition. This was made possible by shaping the thrS operator into two tRNA anticodon arm-like structures.
Experimental procedures
Strains and standard techniques
The Escherichia coli K12 strains used are listed in Table 3 . General genetic and cloning techniques are as already described (Miller, 1972; Sambrook et al., 1989) . For b-galactosidase measurements, bacteria were grown at 30∞C in MOPS medium (Neidhardt et al., 1974) supplemented with glycerol (0.4%), all amino acids (Neidhardt et al., 1977) , tetracyclin (10 mg ml -1 ) and IPTG at 1 mM except when otherwise stated. b-Galactosidase levels were measured as described previously (Miller, 1972) . Oligonucleotide sitedirected mutagenesis was performed on M13mp18EXthrS or M13phaSHthrS using the U-containing DNA method (Kunkel et al., 1987) . Sequencing was performed on M13 phages between the cloning sites used to reintroduce the mutated restriction fragment in the tester plasmid and, afterwards, on the plasmid itself between the same sites.
Plasmid constructions
The tester plasmid, pTetthrSDH was constructed in four steps. First, the bla gene of pTrc99A conferring resistance to ampicillin was partially replaced by a cassette conferring tetracycline resistance. In a second step, a cat cassette was introduced in the polylinker of pTet99. This was done to screen for inserts in the polylinker that replace the cassette. In a third step, the fragment carrying the cat gene was replaced by another fragment carrying thrS without its translational operator to yield pTetthrS. The final plasmid, pTetthrSDH was then obtained by deleting a HindIII fragment EcoRI-XmaI fragment of pTetthrS carrying the 5¢-part of thrS to the 333th codon between the same sites of M13mp18.
M13phaSHthrS
SacII-HindIII fragment of pUB4 carrying the 3¢-terminal part of thrS between the same sites of M13phagescript. pMAK705
cat, lacZa Hamilton et al. (1989) pB1 bla, tet; thrS, infC, rpmI, rplT, pheST Plumbridge et al. (1980) pUC4K bla, kan Vieira and Messing (1982) -1, argE3, DlacX74, mtl-1, xyl-5, tsx-29?, rpsL, argG6, his-4 Plumbridge and Söll (1989) IBPC5421 thi-1, argE3, lacZ(non-polar), galK2, mtl-1, xyl-5, tsx-29?, rpsL, recA1 Springer et al. (1986) IBPC6841pMthrS02 thi-1, argE3, DlacX74, mtl-1, xyl-5, tsx-29?, rpsL, argG6, his-4, thrS-SX::Kan, srl-300::Tn10, recA56, pMthrS02 This work argE3, DlacX74, rpsL, argG6, cI857, nin5; thrS-lacZ. This phage carries a G(-32) to A mutation in the operator. Graffe et al. (1992) from pTetthrS. This cloning reversed the HindIII fragment carrying the tet gene. The details of the cloning are given in Table 3 . Plasmid pTetthrSDH, also called the tester plasmid, carries thrS downstream of the ptrc promoter (an hybrid between the trp -35 and the lac -10 regions) and lacI, which represses thrS expression in the absence of IPTG. When thrS expression is repressed, pTetthrSDH synthesizes almost exactly the same quantity of ThrRS as a chromosomal copy of the gene. When grown in Luria-Bertani broth (LB), the crude extract of a control strain with a wild-type chromosomal copy of thrS has a specific ThrRS activity of 2166 ± 153 pmol of tRNA Thr charged min -1 mg -1 of protein.
IBPC6881pMthrS02
The strain grown under identical conditions but carrying a disruption of the thrS chromosomal gene and pTetthrSDH has the same specific ThrRS activity. An extract made from a strain carrying the induced tester plasmid with the wild-type thrS gene, has a ThrRS specific activity of 52 365 ± 332 pmol of tRNA Thr charged min -1 mg -1 of protein. Therefore, the overproduction, under induced conditions, is about 25-fold.
The resident plasmid, pSGUB4, was constructed by cloning a fragment carrying thrS without its promoter in pSG335. The details of the cloning are summarized in Table 3 . The resulting plasmid carries thrS under the control of plac. The plasmid also carries the B. subtilis sacB gene that kills E. coli in the presence of saccharose.
Construction of the thrS deleted strain
A disruption of the thrS gene was constructed as described previously (Hamilton et al., 1989) . The disruption was first constructed on a pMAK705 derivative and then recombined into the chromosome. The details of the construction of pMthrS02KanSX are given in Table 3 . In this plasmid, the kan cassette is inserted between the first nucleotide of the 120th codon and the 182th codon of thrS.
IBPC5321 was transformed with pMthrS02KanSX. Because the replication of this plasmid is thermosensitive, growth of the transformants at 44∞C in the presence of chloramphenicol forces integration in the chromosome. After integration at 44∞C, resolution was performed at 30∞C. Strains carrying thrS::kan on the chromosome and wild-type thrS on the plasmid were recognized via their thermosensitive phenotype in the absence of chloramphenicol. The presence of wild-type thrS on the plasmid was also confirmed by restriction mapping of mini-prep DNA. Such a strain was transduced to recA56 using P1vir grown on IBPC101 to avoid any further recombination and called IBPC6841 pMthrS02. The presence of the thrS::kan allele in the chromosome of this strain was confirmed by polymerase chain reaction (PCR). Finally, a Tet-sensitive derivative of this strain was made as described previously (Maloy and Nunn, 1981) . The resulting strain, called IBPC6881pMthrS02, was first transformed with pSU4, a plasmid carrying thrS, and then cured of pMthrS02 by growth at high temperature. The resulting strain, IBPC6881pSU4 was finally transformed with pSGUB4. Chloramphenicol-resistant, ampicillin-sensitive clones (loss of pSU4) were screened for and called IBPC6881pSGUB4.
Complementation test
The strain used for the complementation studies, IBPC6881pSGUB4, has the chromosomal copy of thrS disrupted by a cassette conferring kanamycin resistance. As thrS is essential, the gene was provided by the resident plasmid, pSGUB4, conferring resistance to chloramphenicol. This plasmid is compatible with the tester plasmid and carries the Bacillus subtilis sacB gene. In the presence of saccharose, any strain that carries such a plasmid is killed. Complementation was performed as follows. The tester strain carrying the resident plasmid was transformed with the tester plasmid. The transformed cells were grown in the presence of tetracycline, which selects for the presence of the tester plasmid but without selection for the resident plasmid. This step permits segregation of the resident plasmid if the ThrRS synthesized from the tester plasmid is active enough. The cells were then plated in the presence of saccharose (5%), which kills any cell that has not lost the resident plasmid. The latter plating is done in the presence or absence of IPTG (1 mM). If the ThrRS synthesized from the tester plasmid is active, a high proportion of the plated cells grows on the saccharose plates in the absence of IPTG. If the ThrRS of the tester plasmid is less active, cells will appear on the saccharose plates only in the presence of IPTG because overproduction will compensate for the partial loss of activity. If ThrRS synthesized from the tester plasmid is inactive, no cells appear on the saccharose plates, even in the presence of IPTG. With all tester plasmids used in this work, we were always able to lose the resident plasmid either in the absence or in the presence of IPTG. The transformed strains were purified, resident plasmid loss was checked by chloramphenicol sensitivity and growth was tested in the presence or absence of IPTG. The capacity of the mutated plasmids to complement was judged by the colony size under induced and non-induced conditions on LB plates supplemented with tetracycline (10 mg ml -1 ) with or without IPTG (1 mM). More quantitative data (not shown) were obtained by measuring doubling times under non-induced conditions in minimal MOPS medium supplemented with glucose (0.2%), arginine, histidine (Neidhardt et al., 1974) and tetracyclin (10 mg ml -1 ).
RNAs and enzyme preparations
Wild-type thrS RNA fragments corresponding to nucleotides -221 to +61 (+1 being the A of the thrS translational initiation codon) were synthesized by in vitro transcription with T7 RNA polymerase from plasmids linearized with HindIII.
Wild-type threonyl-tRNA synthetase was purified from the E. coli overproducing strain IBPC6183 at 4∞C as described previously (Brunel et al., 1993) . The mutant enzymes were purified from IBPC6881 complemented with derivatives of pTetthrSDH carrying the different mutations. Bacterial growth was at 30∞C in the presence of 1 mM IPTG and 10 mg ml -1 of tetracycline. Purification was adapted from that of the wildtype ThrRS (Brunel et al., 1993) . The pooled active fractions were concentrated and dialysed against the storage buffer (25 mM Hepes-KOH pH 7.5, 2 mM MgCl 2 , 50 mM KCl, 5 mM b-mercaptoethanol, 50% glycerol). All steps were carried out at 4∞C. The activity of the enzyme was measured by the rate of threonyl-tRNA formation as described (Théobald et al., 1988) .
Initial rates of reaction (v) were measured at 37∞C at various tRNA 2 Thr concentrations (90-2 mM) in the absence or the presence of the renatured thrS transcripts (25 nM to 1 mM) as described .
Footprinting experiments
Complex formation between thrS mRNA (15 nM) and wildtype or mutant ThrRS (0.1-5 mM) was performed at 4∞C for 10 min in a 25 ml buffer A containing 50 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 and 50 mM KCl in the presence of 1 mM DTE. Hydrolysis with RNase T1 (0.001 unit) was performed at 20∞C for 5 min Fe(II)-EDTA reactions were carried out in the presence of 2 mM Fe(SO 4 ) 2 (NH4) 2 , 4 mM EDTA, 1 mM DTE, 0.12% H 2 O 2 for 10 min at 4∞C. Incubation controls were also performed in parallel to detect nicks in the RNA or pauses of reverse transcriptase. All reactions were stopped by phenolchloroform extraction, followed by ethanol precipitation. The modified RNAs were hybridized with the 5¢-end labelled oligonucleotide CTTGGGCTTACAGCG (complementary to nucleotides +47 to +61) and cDNA synthesis was performed with one unit of AMV reverse transcriptase (Life Sciences) as described previously (Brunel et al., 1993) .
Toeprinting assays
The formation of a simplified translational initiation complex and the conditions of inhibition of reverse transcriptase extension were as described previously (Moine et al., 1990) .
Graphic modelling
The three-dimensional model of the thrS mRNA (nucleotides U-4 to G-118) interacting with ThrRS was built using several algorithms (Westhof, 1993) incorporated in the program MANIP (Massire and Westhof, 1998) . The three-dimensional model was built using the crystallographic structures of the tRNA-ThrRS (Sankaranarayanan et al., 1999) and the domain 2-DNThrRS complexes (Torres-Larios et al., 2002) . The generated model was subjected to restrained leastsquares refinement using the programs NUCLIN and NUCLSQ (Westhof, 1993) to ensure geometry and stereochemistry with allowed distances between interacting atoms and to avoid steric conflicts. The colour views were generated with the program DRAWNA (Massire et al., 1994) .
